Financhill
Sell
48

STE Quote, Financials, Valuation and Earnings

Last price:
$238.13
Seasonality move :
7.72%
Day range:
$237.18 - $242.71
52-week range:
$200.98 - $252.79
Dividend yield:
0.94%
P/E ratio:
39.14x
P/S ratio:
4.40x
P/B ratio:
3.62x
Volume:
918.4K
Avg. volume:
569.6K
1-year change:
9.12%
Market cap:
$23.9B
Revenue:
$5.5B
EPS (TTM):
$6.20

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
STE
Steris PLC
$1.4B $2.27 6.5% 55.14% $263.10
IVF
INVO Fertility
$1.7M -- -8.8% -- --
NMTC
NeuroOne Medical Technologies
$1.8M -- 120.4% -57.14% $1.45
NTRB
Nutriband
$665K -$0.17 59.2% -13.33% $15.00
SINT
SINTX Technologies
$400K -$0.79 5.82% -78.12% $28.00
ZBH
Zimmer Biomet Holdings
$2.1B $1.98 5.87% 67.9% $107.50
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
STE
Steris PLC
$242.66 $263.10 $23.9B 39.14x $0.57 0.94% 4.40x
IVF
INVO Fertility
$0.86 -- $1.8M -- $0.00 0% 0.08x
NMTC
NeuroOne Medical Technologies
$0.70 $1.45 $34.9M -- $0.00 0% 3.62x
NTRB
Nutriband
$8.02 $15.00 $89.3M -- $0.00 0% 37.11x
SINT
SINTX Technologies
$3.19 $28.00 $8M -- $0.00 0% 3.06x
ZBH
Zimmer Biomet Holdings
$94.06 $107.50 $18.6B 20.81x $0.24 1.02% 2.47x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
STE
Steris PLC
23.64% 0.478 9.17% 1.19x
IVF
INVO Fertility
65.97% 1.151 20.29% 0.05x
NMTC
NeuroOne Medical Technologies
-- 0.459 -- 0.93x
NTRB
Nutriband
3.43% 1.334 0.24% 3.31x
SINT
SINTX Technologies
2.11% 1.788 1.98% 2.98x
ZBH
Zimmer Biomet Holdings
36.67% -0.270 32.03% 1.27x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
STE
Steris PLC
$641.2M $279.6M 6.94% 9.5% 14.48% $189.9M
IVF
INVO Fertility
$592.3K -$2.5M -313.33% -714.24% -1044.01% -$3.6M
NMTC
NeuroOne Medical Technologies
$771.1K -$2.7M -281.01% -281.01% -163.76% -$59.3K
NTRB
Nutriband
$252K -$1.4M -100.04% -102.63% -207.21% -$1.3M
SINT
SINTX Technologies
$45K -$2.4M -177.02% -180.99% -783.16% -$1.4M
ZBH
Zimmer Biomet Holdings
$1.4B $338.9M 4.85% 7.29% 15.46% $335.8M

Steris PLC vs. Competitors

  • Which has Higher Returns STE or IVF?

    INVO Fertility has a net margin of 9.84% compared to Steris PLC's net margin of -1063.02%. Steris PLC's return on equity of 9.5% beat INVO Fertility's return on equity of -714.24%.

    Company Gross Margin Earnings Per Share Invested Capital
    STE
    Steris PLC
    43.31% $1.48 $8.7B
    IVF
    INVO Fertility
    36.18% -$12.53 $9.8M
  • What do Analysts Say About STE or IVF?

    Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 8.42%. On the other hand INVO Fertility has an analysts' consensus of -- which suggests that it could grow by 600.61%. Given that INVO Fertility has higher upside potential than Steris PLC, analysts believe INVO Fertility is more attractive than Steris PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    STE
    Steris PLC
    3 4 0
    IVF
    INVO Fertility
    0 0 0
  • Is STE or IVF More Risky?

    Steris PLC has a beta of 0.923, which suggesting that the stock is 7.704% less volatile than S&P 500. In comparison INVO Fertility has a beta of 2.045, suggesting its more volatile than the S&P 500 by 104.471%.

  • Which is a Better Dividend Stock STE or IVF?

    Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.94%. INVO Fertility offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. INVO Fertility pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios STE or IVF?

    Steris PLC quarterly revenues are $1.5B, which are larger than INVO Fertility quarterly revenues of $1.6M. Steris PLC's net income of $145.7M is higher than INVO Fertility's net income of -$17.4M. Notably, Steris PLC's price-to-earnings ratio is 39.14x while INVO Fertility's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.40x versus 0.08x for INVO Fertility. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STE
    Steris PLC
    4.40x 39.14x $1.5B $145.7M
    IVF
    INVO Fertility
    0.08x -- $1.6M -$17.4M
  • Which has Higher Returns STE or NMTC?

    NeuroOne Medical Technologies has a net margin of 9.84% compared to Steris PLC's net margin of -163.76%. Steris PLC's return on equity of 9.5% beat NeuroOne Medical Technologies's return on equity of -281.01%.

    Company Gross Margin Earnings Per Share Invested Capital
    STE
    Steris PLC
    43.31% $1.48 $8.7B
    NMTC
    NeuroOne Medical Technologies
    55.61% -$0.07 $1.1M
  • What do Analysts Say About STE or NMTC?

    Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 8.42%. On the other hand NeuroOne Medical Technologies has an analysts' consensus of $1.45 which suggests that it could grow by 107.14%. Given that NeuroOne Medical Technologies has higher upside potential than Steris PLC, analysts believe NeuroOne Medical Technologies is more attractive than Steris PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    STE
    Steris PLC
    3 4 0
    NMTC
    NeuroOne Medical Technologies
    1 0 0
  • Is STE or NMTC More Risky?

    Steris PLC has a beta of 0.923, which suggesting that the stock is 7.704% less volatile than S&P 500. In comparison NeuroOne Medical Technologies has a beta of 0.749, suggesting its less volatile than the S&P 500 by 25.052%.

  • Which is a Better Dividend Stock STE or NMTC?

    Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.94%. NeuroOne Medical Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. NeuroOne Medical Technologies pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios STE or NMTC?

    Steris PLC quarterly revenues are $1.5B, which are larger than NeuroOne Medical Technologies quarterly revenues of $1.4M. Steris PLC's net income of $145.7M is higher than NeuroOne Medical Technologies's net income of -$2.3M. Notably, Steris PLC's price-to-earnings ratio is 39.14x while NeuroOne Medical Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.40x versus 3.62x for NeuroOne Medical Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STE
    Steris PLC
    4.40x 39.14x $1.5B $145.7M
    NMTC
    NeuroOne Medical Technologies
    3.62x -- $1.4M -$2.3M
  • Which has Higher Returns STE or NTRB?

    Nutriband has a net margin of 9.84% compared to Steris PLC's net margin of -208.09%. Steris PLC's return on equity of 9.5% beat Nutriband's return on equity of -102.63%.

    Company Gross Margin Earnings Per Share Invested Capital
    STE
    Steris PLC
    43.31% $1.48 $8.7B
    NTRB
    Nutriband
    37.75% -$0.12 $5.3M
  • What do Analysts Say About STE or NTRB?

    Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 8.42%. On the other hand Nutriband has an analysts' consensus of $15.00 which suggests that it could grow by 87.03%. Given that Nutriband has higher upside potential than Steris PLC, analysts believe Nutriband is more attractive than Steris PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    STE
    Steris PLC
    3 4 0
    NTRB
    Nutriband
    1 0 0
  • Is STE or NTRB More Risky?

    Steris PLC has a beta of 0.923, which suggesting that the stock is 7.704% less volatile than S&P 500. In comparison Nutriband has a beta of 1.226, suggesting its more volatile than the S&P 500 by 22.565%.

  • Which is a Better Dividend Stock STE or NTRB?

    Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.94%. Nutriband offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. Nutriband pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios STE or NTRB?

    Steris PLC quarterly revenues are $1.5B, which are larger than Nutriband quarterly revenues of $667.4K. Steris PLC's net income of $145.7M is higher than Nutriband's net income of -$1.4M. Notably, Steris PLC's price-to-earnings ratio is 39.14x while Nutriband's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.40x versus 37.11x for Nutriband. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STE
    Steris PLC
    4.40x 39.14x $1.5B $145.7M
    NTRB
    Nutriband
    37.11x -- $667.4K -$1.4M
  • Which has Higher Returns STE or SINT?

    SINTX Technologies has a net margin of 9.84% compared to Steris PLC's net margin of -787.63%. Steris PLC's return on equity of 9.5% beat SINTX Technologies's return on equity of -180.99%.

    Company Gross Margin Earnings Per Share Invested Capital
    STE
    Steris PLC
    43.31% $1.48 $8.7B
    SINT
    SINTX Technologies
    15.46% -$1.29 $6.2M
  • What do Analysts Say About STE or SINT?

    Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 8.42%. On the other hand SINTX Technologies has an analysts' consensus of $28.00 which suggests that it could grow by 777.74%. Given that SINTX Technologies has higher upside potential than Steris PLC, analysts believe SINTX Technologies is more attractive than Steris PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    STE
    Steris PLC
    3 4 0
    SINT
    SINTX Technologies
    1 0 0
  • Is STE or SINT More Risky?

    Steris PLC has a beta of 0.923, which suggesting that the stock is 7.704% less volatile than S&P 500. In comparison SINTX Technologies has a beta of 0.713, suggesting its less volatile than the S&P 500 by 28.749%.

  • Which is a Better Dividend Stock STE or SINT?

    Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.94%. SINTX Technologies offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Steris PLC pays 35.77% of its earnings as a dividend. SINTX Technologies pays out -- of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios STE or SINT?

    Steris PLC quarterly revenues are $1.5B, which are larger than SINTX Technologies quarterly revenues of $291K. Steris PLC's net income of $145.7M is higher than SINTX Technologies's net income of -$2.3M. Notably, Steris PLC's price-to-earnings ratio is 39.14x while SINTX Technologies's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.40x versus 3.06x for SINTX Technologies. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STE
    Steris PLC
    4.40x 39.14x $1.5B $145.7M
    SINT
    SINTX Technologies
    3.06x -- $291K -$2.3M
  • Which has Higher Returns STE or ZBH?

    Zimmer Biomet Holdings has a net margin of 9.84% compared to Steris PLC's net margin of 9.53%. Steris PLC's return on equity of 9.5% beat Zimmer Biomet Holdings's return on equity of 7.29%.

    Company Gross Margin Earnings Per Share Invested Capital
    STE
    Steris PLC
    43.31% $1.48 $8.7B
    ZBH
    Zimmer Biomet Holdings
    71.2% $0.91 $19.6B
  • What do Analysts Say About STE or ZBH?

    Steris PLC has a consensus price target of $263.10, signalling upside risk potential of 8.42%. On the other hand Zimmer Biomet Holdings has an analysts' consensus of $107.50 which suggests that it could grow by 14.29%. Given that Zimmer Biomet Holdings has higher upside potential than Steris PLC, analysts believe Zimmer Biomet Holdings is more attractive than Steris PLC.

    Company Buy Ratings Hold Ratings Sell Ratings
    STE
    Steris PLC
    3 4 0
    ZBH
    Zimmer Biomet Holdings
    5 17 1
  • Is STE or ZBH More Risky?

    Steris PLC has a beta of 0.923, which suggesting that the stock is 7.704% less volatile than S&P 500. In comparison Zimmer Biomet Holdings has a beta of 0.710, suggesting its less volatile than the S&P 500 by 28.957%.

  • Which is a Better Dividend Stock STE or ZBH?

    Steris PLC has a quarterly dividend of $0.57 per share corresponding to a yield of 0.94%. Zimmer Biomet Holdings offers a yield of 1.02% to investors and pays a quarterly dividend of $0.24 per share. Steris PLC pays 35.77% of its earnings as a dividend. Zimmer Biomet Holdings pays out 21.69% of its earnings as a dividend. Both of these payout ratios are sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios STE or ZBH?

    Steris PLC quarterly revenues are $1.5B, which are smaller than Zimmer Biomet Holdings quarterly revenues of $1.9B. Steris PLC's net income of $145.7M is lower than Zimmer Biomet Holdings's net income of $182M. Notably, Steris PLC's price-to-earnings ratio is 39.14x while Zimmer Biomet Holdings's PE ratio is 20.81x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Steris PLC is 4.40x versus 2.47x for Zimmer Biomet Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    STE
    Steris PLC
    4.40x 39.14x $1.5B $145.7M
    ZBH
    Zimmer Biomet Holdings
    2.47x 20.81x $1.9B $182M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Where Will Hershey Stock Be In 1 Year?
Where Will Hershey Stock Be In 1 Year?

Chocolate stocks used to be the epitome of sleepy stability,…

Where Will KNOT Stock Be In 1 Year?
Where Will KNOT Stock Be In 1 Year?

In the case of KNOT Offshore Partners (KNOP), most headlines…

Why Is Goldman Sachs Stock Up So Much?
Why Is Goldman Sachs Stock Up So Much?

Investment banking giant Goldman Sachs (NYSE:GS) has sharply outperformed the…

Stock Ideas

Buy
63
Is NVDA Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 52x

Buy
60
Is MSFT Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 42x

Sell
48
Is AAPL Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 35x

Alerts

Sell
18
CNC alert for Jul 3

Centene [CNC] is down 40.18% over the past day.

Sell
12
MOH alert for Jul 3

Molina Healthcare [MOH] is down 22.06% over the past day.

Buy
67
GBX alert for Jul 3

Greenbrier Companies [GBX] is up 21.28% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock